← Back to Search

Behavioral Intervention

STAMP+CBT mHealth for Cancer Pain

N/A

Recruiting

Led By Desiree Azizoddin, PsyD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Chronic pain related to cancer or treatment (> pain score of 4)

Be older than 18 years old

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up6 months

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will test a new app designed to help cancer patients with pain.

Eligible Conditions

Cancer
Cancer Treatment
Palliative Care
Cancer Pain

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You have ongoing and significant pain caused by cancer or its treatment (pain score of 4 or higher).

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability Rate

Overall Intervention Adherence Rate

Secondary outcome measures

COMPREHENSIVE ENDPOINT

Study Accrual Rate

Study retention

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: STAMP+CBT PILOTExperimental Treatment1 Intervention

Patients in this Pilot Cohort will be in the research study for 6 weeks total including: a 4-week intervention period and 2-week post intervention period. Patients will use the app for a total of 4 weeks (4-week intervention period), and will complete surveys at baseline, 4 weeks (end of intervention period), and at 6 weeks (end of 2-week post intervention period).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor

1,058 Previous Clinical Trials

338,984 Total Patients Enrolled

1 Trials studying Palliative Care

104 Patients Enrolled for Palliative Care

National Palliative Care Research Center (NPCRC)UNKNOWN

1 Previous Clinical Trials

62 Total Patients Enrolled

Desiree Azizoddin, PsyDPrincipal InvestigatorDana-Farber Cancer Institute

1 Previous Clinical Trials

35 Total Patients Enrolled

Media Library

STAMP+CBT application (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05403801 — N/A

Palliative Care Research Study Groups: STAMP+CBT PILOT

Palliative Care Clinical Trial 2023: STAMP+CBT application Highlights & Side Effects. Trial Name: NCT05403801 — N/A

STAMP+CBT application (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05403801 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for participants in this experiment?

"According to information posted on clinicaltrials.gov, this study is still enrolling patients; the first posting was made in July 2022 and it has been updated as recently as November 17th of that same year."

Answered by AI

How many individuals are currently involved in this clinical experiment?

"Affirmative. The information hosted on clinicaltrials.gov suggests that this medical trial, which was first published on July 1st 2022, is actively seeking applicants. Specifically, it requires 15 participants across 3 distinct sites to be recruited."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

STAMP+CBT mHealth for Cancer Pain

Desiree R. Azizoddin PsyD 2022. "STAMP+CBT mHealth for Cancer Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05403801.

All > Health